Also trades as: LSBCF (OTC) · $vol 0M
LSB NASDAQ
LakeShore Biopharma Co., Ltd
1W: +1.3%
1M: -2.7%
3M: -25.0%
1Y: -79.4%
3Y: -99.2%
$0.63
Last traded 2025-10-16 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.4B
-9.6% ▼
4Y CAGR: +1006.1%
Total Liabilities
$868M
-6.5% ▼
4Y CAGR: +955.2%
Shareholders Equity
$500M
-14.6% ▼
4Y CAGR: -10.4%
Cash & Investments
$28M
-88.6% ▼
4Y CAGR: -48.2%
Total Debt
$414M
-2.4% ▼
4Y CAGR: +117.0%
Net Debt
$386M
+116.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $390M | $271M | $370M | $246M | $28M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $390M | $271M | $370M | $246M | $28M |
| Net Receivables | $215M | $309M | $468M | $444M | $502M |
| Inventory | $81M | $167M | $185M | $203M | $228M |
| Other Current Assets | $34M | $8M | $577K | $3M | $79M |
| Total Current Assets | $733M | $765M | $1.0B | $903M | $842M |
| Property, Plant & Equip. | $253M | $565M | $583M | $481M | $414M |
| Goodwill & Intangibles | $84M | $81M | $78M | $71M | $73M |
| Long-Term Investments | -$345M | $200M | $0 | $0 | $0 |
| Other Non-Current Assets | $91K | -$649M | $21M | $34M | $10M |
| Total Non-Current Assets | $91K | $200M | $684M | $610M | $525M |
| Total Assets | $91K | $201M | $1.7B | $1.5B | $1.4B |
| — Liabilities — | |||||
| Accounts Payable | $16M | $31M | $80M | $68M | $50M |
| Short-Term Debt | $263K | $112M | $194M | $319M | $390M |
| Deferred Revenue | $2M | $2M | $2M | $2M | $1M |
| Other Current Liabilities | $149M | -$381M | $109M | $119M | $100M |
| Total Current Liabilities | $345M | $143K | $659M | $802M | $825M |
| Long-Term Debt | $1M | $254M | $294M | $99M | $24M |
| Other Non-Current Liab. | $1.3B | $30M | $9M | $5M | $3M |
| Total Non-Current Liabilities | $1.3B | $295M | $333M | $126M | $43M |
| Total Liabilities | $70K | $20M | $991M | $928M | $868M |
| — Equity — | |||||
| Common Stock | $8K | $8K | $12K | $26K | $29K |
| Retained Earnings | -$1.4B | -$1.6B | -$1.9B | -$2.3B | -$2.4B |
| Accumulated OCI | $44M | $83M | -$54M | -$58M | -$57M |
| Total Stockholders Equity | $777M | $671M | $728M | $585M | $500M |
| Total Liabilities & Equity | $91K | $201M | $1.7B | $1.5B | $1.4B |
| — Key Metrics — | |||||
| Total Debt | $19M | $381M | $499M | $424M | $414M |
| Net Debt | -$372M | $110M | $129M | $178M | $386M |
| Total Investments | -$345M | $200M | $0 | $0 | $0 |